COMMUNIQUÉS West-GlobeNewswire

Seer to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
26/08/2025
REDWOOD CITY, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the company will be participating in the [...]
Sana Biotechnology to Present at September 2025 Investor Conferences
26/08/2025
SEATTLE, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its [...]
iMDx to Participate in NYC Investment Conferences September 8 - 11
26/08/2025
NASHVILLE, Tenn., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., or iMDx, (Nasdaq: IMDX), today announced participation in investor conferences hosted by both H.C. Wainwright and Lake Street [...]
Immuneering Announces Closing of $25 Million Private Placement
26/08/2025
CAMBRIDGE, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer patients alive, today announced the closing of its previously [...]
IRADIMED CORPORATION to Participate in the 2025 Wells Fargo Healthcare Conference
26/08/2025
ORLANDO, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in innovative medical devices for Magnetic Resonance Imaging (“MRI”) compatible patient monitoring and infusion systems, [...]
Zentalis Pharmaceuticals Appoints James B. Bucher, JD, as Chief Legal Officer and Corporate Secretary
26/08/2025
Seasoned life sciences legal executive brings extensive public company experience, including broad strategic and financial transaction expertise SAN DIEGO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, [...]
Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference
26/08/2025
MENLO PARK, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Sight Sciences , Inc. (Nasdaq: SGHT) (Sight Sciences or the Company) an eyecare technology company focused on developing and commercializing innovative, [...]
NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share
26/08/2025
EMERYVILLE, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces its Board of Directors and the Special Transaction Committee of the Board [...]
SI-BONE to Present at Morgan Stanley 23rd Global Healthcare Conference on September 9, 2025
26/08/2025
SANTA CLARA, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the [...]
Cognition Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
26/08/2025
PURCHASE, N.Y., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, was [...]
Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences
26/08/2025
NEWTON, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta oligomers for [...]
BioXcel Therapeutics To Announce Topline Results from SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia on August 27, 2025
26/08/2025
Company to host conference call at 8 a.m. ET, August 27, 2025 NEW HAVEN, Conn., Aug. 26, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence [...]
Plus de 2 000 opérations chirurgicales effectuées avec succès dans des cas d’épilepsie pharmaco-résistante
26/08/2025
KFSHRC réalise une avancée majeure dans le traitement de l’épilepsie grâce à la SEEG RIYAD, Arabie saoudite, 26 août 2025 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (KFSHRC) a renforcé [...]
Tevogen Expresses Gratitude to Yale for Recognition of Dr. Ryan Saadi and Company’s Mission of Health Equity
26/08/2025
WARREN, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today expressed its appreciation to Yale University for recognizing Founder and CEO Dr. Ryan Saadi, MPH [...]
KFSHRC Saves Saudi 7-Year-Old Through Cross-Border Heart Transplant with UAE Donor
26/08/2025
RIYADH, Saudi Arabia, Aug. 26, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has successfully performed a life-saving heart transplant on a 7-year-old Saudi child using [...]
PEMF Therapy Emerges as a Leading 2025 Wellness Trend for Drug-Free Pain Relief; Grooni Earthing’s Pro Collection Meets Rising Demand
26/08/2025
SHERIDAN, WY , Aug. 26, 2025 (GLOBE NEWSWIRE) -- As consumers seek science-informed, non-pharmacological options for chronic pain and recovery, pulsed electromagnetic field (PEMF) therapy is gaining momentum. Market [...]
Becker’s Healthcare Names U.S. Oral Surgery Management to 2025 DSOs to Know List
26/08/2025
IRVING, Texas, Aug. 26, 2025 (GLOBE NEWSWIRE) -- For the second year in a row, Becker’s Healthcare has named U.S. Oral Surgery Management ( USOSM ) to this year’s DSOs to Know list. Honorees are selected by Becker’s, [...]
Trethera Awarded $2.3 Million NIH Grant to Study TRE-515 Combined with Radiation Therapy in Prostate Cancer Preclinical Models
26/08/2025
LOS ANGELES, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, announced today the [...]
PCI Biotech: Invitation to first half 2025 results presentation and corporate update
26/08/2025
Oslo, Norway, 26 August 2025 - PCI Biotech (OSE: PCIB) invites to a webcast presentation of the company's first half 2025 interim report on Friday, 29 August 2025, 08:30am – 09:00am CET (local time). The presentation [...]

Pages